Researchers from the National University of Singapore (NUS) have developed a "capping-and-coupling" strategy to transform naturally occurring (native) sugars directly into compounds known as ...
During the preclinical stage, the focus of forecasting is not necessarily on the product itself, but on the broader opportunity within the disease area. At this point, there is limited information ...
A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water. For most treatments, the oral route remains the gold ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in ...
Ireland is attracting major investment from the largest pharma companies in the world. Ben Hargreaves finds out how the country has become one of the most significant locations in Europe for ...
Jan 30 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results